Home » Featured Slider » SynBioBeta COVID-19 Town Hall: How can synthetic biologists contribute to the response?

SynBioBeta COVID-19 Town Hall: How can synthetic biologists contribute to the response?

Here is an important conversation among synthetic biology innovators to explore how the synthetic biology industry can help respond to the COVID-19 outbreak. This town hall style webinar provides an update from some of the front-line thinkers and doers tackling the technical and social challenges to preventing a global pandemic. Everyone is welcome, and if you’re also working on COVID-19, we invite you to join and we’ll try to give everyone a minute to share their diverse perspectives. 

  • Trevor Martin, Co-Founder and CEO of Mammoth Biosciences, on ultra-rapid development of CRISPR based COVID-19 testing
  • Jake Glanville, Founding Partner and CEO of Distributed Bio, on developing vaccines for coronavirus and the next pandemic
  • Megan Palmer, Senior Research Scholar at the Center for International Security and Cooperation (CISAC), on proactive approaches for health security in synthetic biology

coronavirus webinar

Your host:

John Cumbers, Founder & CEO, SynBioBeta

Saturday, March 7, 9:00 – 10:00 am Pacific

Background: A number of synthetic biology companies are racing to fight coronavirus. But according to NIH, it could take a year and a half before a vaccine is ready for people. 

What’s more, the White House acknowledges there is a shortfall in the number of testing kits required to meet demand. This town hall style webinar will bring together leading innovators and thinkers to explore what the synthetic biology community can contribute to an effective COVID-19 response. We’ll explore ultra-rapid development of CRISPR- based diagnostics, the vaccine pathway and efforts to develop universal vaccines, and what policies and practices can promote global health security during this and future outbreaks.

 

7
John Cumbers

John Cumbers

John Cumbers is the founder of SynBioBeta. John is passionate about education and on the use and adoption of biological technologies. He has received multiple awards and grants from NASA and the National Academy of Sciences for his work in the field. John has been involved in multiple startups such as those producing food for space, microbes to extract lunar and martian resources, and hoverboards! John is an active investor through the DCVC SynBioBeta Fund and his synthetic biology syndicate on AngelList.

Click here to join our weekly newsletter. We want to hear what you think about this article. Got a tip for our news team? Write to editorial@synbiobeta.com.

Editor’s picks